• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Astellas Pharma

Fly fishing
CRO

Evinova reels in AI partnerships with Astellas and AZ deals

Astellas Pharma and AstraZeneca are joining Bristol Myers Squib by partnering with Evinova’s AI platform that aims to speed up clinical development.
Will Maddox Feb 24, 2026 12:00pm
Darts failing to hit bullseye

Aviceda eye disease hopeful fails to top Astellas med in phase 2

Dec 15, 2025 2:14pm
Parachute over a mountain in Switzerland

GSK chief steps down in stunning move—Chutes & Ladders

Oct 3, 2025 8:30am
Astellas

Astellas offers lab space to help Japanese biotechs 'go global'

Jun 13, 2025 4:41am
Astellas

Astellas stops development of early-stage lymphoma CAR-T

Jan 9, 2025 6:49am
colorful brain art model

Astellas pays Sangamo $20M to boost neurological gene therapies

Dec 19, 2024 7:13am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings